ATE248216T1 - Ersatztherapie für zahnkaries - Google Patents

Ersatztherapie für zahnkaries

Info

Publication number
ATE248216T1
ATE248216T1 AT96918381T AT96918381T ATE248216T1 AT E248216 T1 ATE248216 T1 AT E248216T1 AT 96918381 T AT96918381 T AT 96918381T AT 96918381 T AT96918381 T AT 96918381T AT E248216 T1 ATE248216 T1 AT E248216T1
Authority
AT
Austria
Prior art keywords
dental caries
replacement therapy
recombinant
mutans strains
production
Prior art date
Application number
AT96918381T
Other languages
English (en)
Inventor
Jeffrey D Hillman
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE248216T1 publication Critical patent/ATE248216T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
AT96918381T 1995-06-07 1996-06-07 Ersatztherapie für zahnkaries ATE248216T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/486,037 US5607672A (en) 1995-06-07 1995-06-07 Replacement therapy for dental caries
PCT/US1996/009667 WO1996040865A1 (en) 1995-06-07 1996-06-07 Replacement therapy for dental caries

Publications (1)

Publication Number Publication Date
ATE248216T1 true ATE248216T1 (de) 2003-09-15

Family

ID=23930361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918381T ATE248216T1 (de) 1995-06-07 1996-06-07 Ersatztherapie für zahnkaries

Country Status (15)

Country Link
US (1) US5607672A (de)
EP (1) EP0832186B1 (de)
JP (1) JP4027970B2 (de)
CN (1) CN1149280C (de)
AT (1) ATE248216T1 (de)
AU (1) AU702384B2 (de)
BR (1) BR9609041A (de)
CA (1) CA2223906C (de)
DE (1) DE69629689T2 (de)
DK (1) DK0832186T3 (de)
ES (1) ES2205038T3 (de)
NZ (1) NZ310289A (de)
PT (1) PT832186E (de)
RU (1) RU2224794C2 (de)
WO (1) WO1996040865A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964760B2 (en) 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US6475771B1 (en) 1997-06-10 2002-11-05 University Of Florida Research Foundation Antimicrobial polypeptides and methods of use
US5932469A (en) 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6218362B1 (en) 1997-09-08 2001-04-17 Universite Laval Lantibiotic from Streptococcus mutans and uses thereof
DE10108900B4 (de) 2001-02-23 2005-03-10 3M Espe Ag Ermittlung des patientenbezogenen Kariesrisikos
EP1287745A1 (de) 2001-08-24 2003-03-05 The Procter & Gamble Company Kaubare Zusammmensetzung mit Probiotika
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
NZ545730A (en) * 2003-08-11 2009-08-28 Oragenics Inc Compositions and methods for the maintenance of oral health
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US9968526B1 (en) 2005-01-24 2018-05-15 Dental Alliance Holdings, Lll System for caries management by risk assessment
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
CA2636236C (en) * 2006-01-04 2016-08-16 Maude Wikstroem Probiotic oral health promoting product
US9427384B2 (en) 2006-01-23 2016-08-30 Dental Alliance Holdings, Llc System for caries management by risk assessment
US10143633B2 (en) 2006-10-16 2018-12-04 Dental Alliance Holdings, Llc Treating cariogenic diseased oral biofilm with elevated pH
KR20110025798A (ko) * 2008-06-13 2011-03-11 오라제닉스, 인코포레이티드 치아 미백용 과산화수소-생산 세균의 용도
CA2738781C (en) 2008-09-29 2020-06-09 Intrexon Actobiotics Nv Reduced colonization of microbes at the mucosa
ES2608577T3 (es) * 2010-08-31 2017-04-12 Centro Superior De Investigación En Salud Pública (Csisp) Composiciones y probióticos/prebióticos anticaries
EP3484442A1 (de) 2016-07-15 2019-05-22 Intrexon Corporation Lantibiotische varianten und verwendungen davon
EP3720458A4 (de) 2017-12-05 2021-12-08 BioPlx, Inc. Verfahren und zusammensetzungen zur verhinderung von mikrobieller infektion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324860A (en) * 1978-02-23 1982-04-13 Forsyth Dental Infirmary For Children Lactate dehydrogenase mutants of Streptococcus mutans
US4133875A (en) * 1978-02-23 1979-01-09 Forsyth Dental Infirmary For Children Method of controlling dental caries with streptococcus mutans mutant strains

Also Published As

Publication number Publication date
EP0832186B1 (de) 2003-08-27
JPH11507228A (ja) 1999-06-29
CA2223906A1 (en) 1996-12-19
PT832186E (pt) 2004-01-30
DK0832186T3 (da) 2003-12-01
DE69629689T2 (de) 2004-06-17
JP4027970B2 (ja) 2007-12-26
ES2205038T3 (es) 2004-05-01
WO1996040865A1 (en) 1996-12-19
MX9709598A (es) 1998-06-30
HK1015410A1 (en) 1999-10-15
NZ310289A (en) 2000-02-28
CA2223906C (en) 2010-04-20
DE69629689D1 (de) 2003-10-02
CN1192234A (zh) 1998-09-02
AU702384B2 (en) 1999-02-18
US5607672A (en) 1997-03-04
CN1149280C (zh) 2004-05-12
EP0832186A4 (de) 2002-03-06
RU2224794C2 (ru) 2004-02-27
EP0832186A1 (de) 1998-04-01
AU6105996A (en) 1996-12-30
BR9609041A (pt) 1999-12-14

Similar Documents

Publication Publication Date Title
ATE248216T1 (de) Ersatztherapie für zahnkaries
EG21210A (en) Process for preparing of antiseptic dentifrice
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
MY113059A (en) Controlled-release dosage forms of azithromycin
BG101949A (bg) Диспергируема частичкова система за десензибилизиране на зъби
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
PL320484A1 (en) Method of treating diabetes using kgf
CA2253287A1 (en) A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
AU6857887A (en) Therapeutic agent
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
AU5323396A (en) Methods of treating inflammation and compositions therefor
ATE236647T1 (de) Verbesserung der wundheilung mit cm101/gbs-toxin
CA2232433A1 (fr) Nouvelle composition reductrice et nouveau procede pour la deformation permanente des cheveux
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ZA969111B (en) Lactic ferments and their use for the production of hypocholesterolaemic products.
IE870577L (en) Topical amide preparation
ATE210460T1 (de) Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben
DE50206172D1 (de) Heil-und pflegemittel auf sauerteigbasis sowie verfahren zu seiner herstellung
DE69627298D1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
UA7955A (uk) Спосіб лікування туберкульозу легенів

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0832186

Country of ref document: EP